| The haloperidol story B Granger, S Albu Annals of Clinical Psychiatry 17 (3), 137-140, 2005 | 141 | 2005 |
| Dynamics of psychotherapy-related cerebral haemodynamic changes in obsessive compulsive disorder using a personalized exposure task in functional magnetic resonance imaging M Morgieve, K N'diaye, WIA Haynes, B Granger, AH Clair, A Pelissolo, ... Psychological Medicine 44 (7), 1461-1473, 2014 | 91 | 2014 |
| Psychopathologie de l'adulte Q Debray, B Granger, F Azais Elsevier Masson, 2012 | 62 | 2012 |
| The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease P Laforêt, K Laloui, B Granger, D Hamroun, N Taouagh, JY Hogrel, ... Revue neurologique 169 (8-9), 595-602, 2013 | 61 | 2013 |
| Dopamine transporter and reward anticipation in a dimensional perspective: a multimodal brain imaging study M Dubol, C Trichard, C Leroy, AL Sandu, M Rahim, B Granger, ... Neuropsychopharmacology 43 (4), 820-827, 2018 | 60 | 2018 |
| Repeatability and variability of baropodometric and spatio-temporal gait parameters–results in healthy subjects and in stroke patients FA Valentini, B Granger, DS Hennebelle, N Eythrib, G Robain Neurophysiologie Clinique/Clinical Neurophysiology 41 (4), 181-189, 2011 | 43 | 2011 |
| Striatal and extrastriatal dopamine transporter availability in schizophrenia and its clinical correlates: a voxel-based and high-resolution PET study E Artiges, C Leroy, M Dubol, M Prat, A Pepin, A Mabondo, ... Schizophrenia bulletin 43 (5), 1134-1142, 2017 | 33 | 2017 |
| The discovery of haloperidol B Granger L'encephale 25 (1), 59-66, 1999 | 30 | 1999 |
| Écrits cliniques E Minkowski, B Granger (No Title), 2002 | 29 | 2002 |
| Lower midbrain dopamine transporter availability in depressed patients: Report from high-resolution PET imaging M Dubol, C Trichard, C Leroy, B Granger, ET Tzavara, JL Martinot, ... Journal of Affective Disorders 262, 273-277, 2020 | 25 | 2020 |
| Dynamic functional connectivity in adolescence-onset major depression: relationships with severity and symptom dimensions R Marchitelli, ML Paillère-Martinot, N Bourvis, C Guerin-Langlois, ... Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 7 (4), 385-396, 2022 | 23 | 2022 |
| Amygdala and regional volumes in treatment‐resistant versus nontreatment‐resistant depression patients AL Sandu, E Artiges, A Galinowski, T Gallarda, F Bellivier, H Lemaitre, ... Depression and anxiety 34 (11), 1065-1071, 2017 | 23 | 2017 |
| Manic depressive illness and tyrosine hydroxylase gene: linkage heterogeneity and association A Malafosse, M Leboyer, T d'Amato, S Amadéo, M Abbar, D Campion, ... Neurobiology of Disease 4 (5), 337-349, 1997 | 23 | 1997 |
| Cognitive and emotional approach to assertiveness F Azais, B Granger, Q Debray, C Ducroix L'encephale 25 (4), 353-357, 1999 | 18 | 1999 |
| Functional disorganization of representations in schizophrenia A Plagnol, B Pachoud, B Claudel, B Granger Schizophrenia bulletin 22 (2), 383-398, 1996 | 17 | 1996 |
| Les nouveaux modèles de soins: une clinique au service de la personne A Plagnol, B Pachoud, B Granger Doin-John Libbey Eurotext, 2018 | 15 | 2018 |
| Population pharmacokinetics of oral baclofen at steady‐state in alcoholic‐dependent adult patients L Chevillard, N Sabo, M Tod, L Labat, C Chasport, C Chevaleyre, ... Fundamental & Clinical Pharmacology 32 (2), 239-248, 2018 | 15 | 2018 |
| Liquid chromatography high resolution mass spectrometry for the determination of baclofen and its metabolites in plasma: Application to therapeutic drug monitoring L Labat, A Goncalves, AR Marques, B Duretz, B Granger, X Declèves Biomedical Chromatography 31 (8), e3936, 2017 | 12 | 2017 |
| La schizophrénie B Granger, J Naudin le Cavalier bleu, 2006 | 10 | 2006 |
| La psychiatrie d'aujourd'hui: du diagnostic au traitement B Granger Odile Jacob, 2002 | 10 | 2002 |
